Norris Medicines Board Approves FY26 Annual Report and 35th AGM Schedule
Norris Medicines Ltd 路 Others (Uncategorized) 路 04 Sept 2026, 12:02 am
Norris Medicines Board Approves FY26 Annual Report and 35th AGM Schedule On 3rd Sep'26, Norris Medicines Limited approved its FY26 Annual Report and Directors' Report. The Board scheduled the 35th AGM for 29th Sep'26 via video conferencing, approving the corresponding book closure and e-voting cut-off dates. Additionally, Purva Sharegistry was appointed to facilitate the e-voting process, with Hemant Shetye designated as the scrutinizer to ensure fair and transparent proceedings.
Original exchange filing (PDF)
More announcements from Norris Medicines Ltd
- Un-audited financial results for the quarter and half year ended 30th September, 2026 路 14 Nov 2026
- Outcome Of Board Meeting Held Today I.E. Saturday, November 14, 2026 路 14 Nov 2026
- Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Un-Audited Financial Results .... 路 14 Nov 2026
- Scrutinizer''s Report and Voting Results of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026 路 30 Sept 2026
- Scrutinizer''s Report and Voting Results of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026 路 30 Sept 2026
- Outcome and proceeding of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026 路 29 Sept 2026
- Outcome and proceeding of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026 路 29 Sept 2026
- Outcome of 35th Annual General Meeting of the Company held on Tuesday, 29th September, 2026 路 29 Sept 2026
